Trademark Trial and Appeal Board Electronic Filing System. http://estta.uspto.gov
`ESTTA627114
`ESTTA Tracking number:
`09/15/2014
`
`Filing date:
`IN THE UNITED STATES PATENT AND TRADEMARK OFFICE
`BEFORE THE TRADEMARK TRIAL AND APPEAL BOARD
`Notice of Opposition
`
`Notice is hereby given that the following party opposes registration of the indicated application.
`Opposer Information
`
`Name
`Granted to Date
`of previous ex-
`tension
`Address
`
`Novartis AG
`09/14/2014
`
`CH-4002
`Basel,
`SWITZERLAND
`
`Attorney informa-
`tion
`
`John P. Margiotta
`Fross Zelnick Lehrman Zissu, P.C.
`866 United Nations Plaza
`New York, NY 10017
`UNITED STATES
`jm@fzlz.com Phone:212-813-5900
`Applicant Information
`
`Application No
`Opposition Filing
`Date
`Applicant
`
`85863458
`09/15/2014
`
`Publication date
`Opposition Peri-
`od Ends
`
`03/18/2014
`09/14/2014
`
`Novarad Corporation
`752 East 1180 South, Suite 200
`American Fork, UT 84003
`UNITED STATES
`Goods/Services Affected by Opposition
`
`Class 042. First Use: 2003/09/08 First Use In Commerce: 2003/09/08
`All goods and services in the class are opposed, namely: Providing online non-downloadable internet
`based software applications for scanning, capturing, registering, analyzing,financially analyzing, com-
`paring, scrolling, enlarging, rotating, managing, tracking, modifying, annotating, deleting, reporting,
`storing, archiving and distributing medical, radiological and digitalimages, films and videos, for use in
`the fields of medical imaging, radiological imaging, digital imaging, medical imaging systems, radiolo-
`gical imaging systems, medical image management, x-ray imaging, magnetic resonance imaging,
`and ultra sound
`
`Grounds for Opposition
`
`Priority and likelihood of confusion
`
`Trademark Act section 2(d)
`
`Marks Cited by Opposer as Basis for Opposition
`
`U.S. Registration
`No.
`Registration Date
`
`2336960
`
`04/04/2000
`
`Application Date
`
`07/09/1996
`
`Foreign Priority
`
`02/15/1996
`
`

`
`Word Mark
`Design Mark
`
`NOVARTIS
`
`Date
`
`Description of
`Mark
`Goods/Services
`
`NONE
`
`Class 001. First use: First Use: 0 First Use In Commerce: 0
`[ chemicals and chemical preparations for use in industry, agriculture, horticul-
`ture and forestry, namely, chemicals for use in manufacturing optical lenses; Ad-
`juvants for use in manufacturing agricultural preparations; Adjuvants for use in
`manufacturing pharmaceutical preparations; Chemical additives for use in man-
`ufacturing - pharmaceutical preparations, defoliants, wound pastes for trees and
`plants, plant growth regulators, preparations for the treatment of seeds, prepara-
`tions for the protection of seeds and plants against plant pathogens, plant pro-
`tection agents of a prophylactic nature; and Manures ]
`Class 005. First use: First Use: 0 First Use In Commerce: 0
`pharmaceutical preparations for the treatment of - dermatological, cardiovascu-
`lar, hematological, bone, respiratory, central nervous system, endocrinological,
`circulatory, gastroenterological, hormonal and diabetic disorders, coughs, colds,
`influenza, headaches, stomach and digestive disorders, muscular and/or rheum-
`atic disorders, anti-inflammatory agents, immune system disorders and related
`diseases, allergic reactions, metabolic disorders, anti-infectives, occular dis-
`orders, and for use in oncology; diagnostic preparations and/or reagents for clin-
`icalor medical laboratory use; Contact lensand eyecare solutions and prepara-
`tions,namely, disinfectants, cleaning solutions, saline solutions and wetting solu-
`tions; Nicotine for medicinal purposes in liquid, pill, tablet, caplet, powder or
`transdermal patch form; [ Hormones; ] Dietetic substances for medical purposes,
`namely, nutritional, vitamin, [ herbal and ] mineral supplements and prepara-
`tions, nutritional drink mix for use as a meal replacement, [ nutritional supple-
`mentsin snack bar form for use as a meal replacement; ] Food and beverages
`for [ babies, ] nfants and invalids, namely, [ baby food, infant formula, ] food for
`enteral administration and food for medically restricted diets; and [ Pesticides, ]
`fungicides, [ herbicides ] and insecticides, all for commercial, [ agricultural ] and/
`or domestic use
`Class 009. First use: First Use: 0 First Use In Commerce: 0
`[ contact lenses; Eyeglasses; Sunglasses; and Optical lenses not for medical
`use ]
`Class 010. First use: First Use: 0 First Use In Commerce: 0
`[ artificial or biological skin tissue for subsequent implantation; Intraocularlenses
`
`] C
`
`lass 029. First use: First Use: 0 First Use In Commerce: 0
`[ prepared entrees consisting primarilyof meat, fish, poultry, game and/or veget-
`ables; Meat extracts; Preserved, dried, frozen or cooked fruits and vegetables;
`Jams and fruit or vegetable preserves;Fruit-based snack foods; Fruit toppings;
`Dairy products, excluding ice cream, ice milk and frozen yogurt; Milk ]
`Class 030. First use: First Use: 0 First Use In Commerce: 0
`[ ready to eat snack bars made from combinations of cereal, fruit, grains and
`nuts; Breakfast and processed cereals; Cereal based snack foods; Bread; Bis-
`
`

`
`cuits;Chocolate; Candy; Cocoa; Sugar; Tapioca; Sago; Rusks; Desserts,
`namely, cakes and puddings; Malt for food purposes; Icecream, frozen yogurt,
`ice milk and ice cream substitute; Chocolate syrup; Corn syrup; and Food addit-
`ives for non-nutritional purposes for use as a flavoring, ingredient or filler ]
`Class 031. First use: First Use: 0 First Use In Commerce: 0
`[ bran, cereal and protein based foodstuffs for animals; Vegetable, fruit and
`flower seeds for agricultural and horticultural purposes; Fresh fruits and veget-
`ables; Living plants and live flowers ]
`Class 032. First use: First Use: 0 First Use In Commerce: 0
`[ non-alcoholic beverages, namely, softdrinks, fruit drinks, fruit juices; Concen-
`trates, syrups or powders used in thepreparation of soft drinks; and Fruit syrups
`used in the preparation of soft drinks ]
`Class 042. First use: First Use: 0 First Use In Commerce: 0
`[ engineering services; plant, tree andseed breeding services; Horticultural ser-
`vices; Printing; and Material testing ]
`
`U.S. Registration
`No.
`Registration Date
`
`Word Mark
`Design Mark
`
`2997235
`
`09/20/2005
`
`NOVARTIS
`
`Application Date
`
`02/10/2004
`
`Foreign Priority
`Date
`
`NONE
`
`Description of
`Mark
`Goods/Services
`
`NONE
`
`Class 005. First use: First Use: 1997/09/30 First Use In Commerce: 1997/09/30
`Adjuvants for use with veterinary vaccines and veterinary vaccines for compan-
`ion animals, farmed fish and livestock; veterinary products for companion anim-
`als,farmed fish and livestock, namely, cardiovascular treatment preparations,
`arthritis treatment preparations, renal treatment preparations, respiratory treat-
`mentpreparations, reproductive treatment preparations, allergy treatment pre-
`parations, antibiotics, insecticides, pesticides and feed additives for veterinary
`use in the treatment of parasites, fleas, worms, renal diseases, heart diseases,
`allergic diseases, parasitic and bacterial infections, lameness, respiratory dis-
`eases, scours or enteritis, viral diseases,clostridial diseases, pinkeye, liver abs-
`
`

`
`cesses, influenza, pneumonia, mastitis,West Nile virus and erysipelas; insect-
`icides and rodenticides for agricultural use, disinfectants for veterinary use
`
`Attachments
`
`75131409#TMSN.png( bytes )
`78365657#TMSN.png( bytes )
`Notice of Opposition (NOVARIS) (F1526823x96B9E).pdf(288364 bytes )
`
`The undersigned hereby certifies that a copy of this paper has been served upon all parties, at their address
`record by First Class Mail on this date.
`
`Certificate of Service
`
`Signature
`Name
`Date
`
`/John P. Margiotta/
`John P. Margiotta
`09/15/2014
`
`

`
`IN THE UNITED STATES PATENT AND TRADEMARK OFFICE
`
`BEFORE THE TRADEMARK TRIAL AND APPEAL BOARD
`
`NOVARTIS AG,
`
`Opposer,
`
`V.
`
`NOVARAD CORPORATION,
`
`Applicant.
`
`NOTICE OF OPPOSITION
`
`Novartis AG (“Opposer”), a corporation organized and existing according to the laws of
`
`Switzerland, located and doing business at CH-4002, Basel, Switzerland, believes that it will be
`
`damaged by the issuance of a registration for the mark NOVARIS, applied for in Application
`
`Serial No. 85/863,458 for “Providing online non-downloadable internet based software
`
`applications for scanning, capturing, registering, analyzing, financially analyzing, comparing,
`
`scrolling, enlarging, rotating, managing, tracking, modifying, annotating, deleting, reporting,
`
`storing, archiving and distributing medical, radiological and digital images, films and videos, for
`
`use in the fields of medical imaging, radiological imaging, digital imaging, medical imaging
`
`systems, radiological imaging systems, medical image management, x-ray imaging, magnetic
`
`resonance imaging, and ultra sound” in International Class 42, and therefore opposes the same.
`
`As grounds for the opposition, Opposer, by its attorneys Fross Zelnick Lehrman & Zissu, P.C.,
`
`alleges as follows:
`
`1.
`
`Opposer is the owner of the trademark and trade name NOVARTIS in connection
`
`with a wide variety of pharmaceutical preparations for human and veterinary medicines.
`
`Opposer has used the mark NOVARTIS in commerce since at least as early as 1997, and the
`
`mark is now famous.
`
`{FlS25865 1
`
`)
`
`

`
`2.
`
`Novartis is the owner of the following U.S. trademark registrations:
`
`0 NOVARTIS, Reg. No. 2,336,960, registered April 4, 2000 for pharmaceuticals in
`
`International Class 5.
`
`0 NOVARTIS, Reg. No. 2,997,235, registered September 20, 2005, for veterinary
`
`pharmaceuticals in International Class 5.
`
`3.
`
`These registrations are valid, subsisting and in full force and effect, and constitute
`
`evidence of the validity of the marks and of Opposer’s exclusive right to use them on the goods
`
`identified in the registrations. Both registrations have also become incontestable under
`
`Section 15 of the Trademark Act. Printouts from the United States Patent and Trademark
`
`Office’s online databases reflecting these registrations are attached as Exhibit A.
`
`4.
`
`On information and belief, Novarad Corporation (“Applicant”) is a corporation
`
`organized and existing according to the laws of Utah, located and doing business at 752 East
`
`1180 South, Suite 200, American Fork, Utah 84003.
`
`5.
`
`On February 28, 2013, Applicant filed Application Serial No. 85/863,458 to
`
`register the mark NOVARIS for use in connection with “Providing online non-downloadable
`
`internet based software applications for scanning, capturing, registering, analyzing, financially
`
`analyzing, comparing, scrolling, enlarging, rotating, managing, tracking, modifying, annotating,
`
`deleting, reporting, storing, archiving and distributing medical, radiological and digital images,
`
`films and videos, for use in the fields of medical imaging, radiological imaging, digital imaging,
`
`medical imaging systems, radiological imaging systems, medical image management, X-ray
`
`imaging, magnetic resonance imaging, and ultra sound” in International Class 42 (the
`
`“Application”), based on an intent to use said mark.
`
`6.
`
`The Application filing date, and any other date Applicant can rely on, is after
`
`Opposer’s first use date for its NOVARTIS mark.
`
`(F1525865 1
`
`)
`
`2
`
`

`
`7.
`
`The Application filing date, and any other date Applicant can rely on, is also long
`
`after Opposer’s NOVARTIS mark had become famous.
`
`8.
`
`The mark NOVARIS to be registered by Applicant is confusingly similar in
`
`sound, appearance, and commercial impression to Opposer’s registered, long-used and famous
`
`trademark NOVARTIS, in that NOVARIS comprises the NOVARTIS mark but for the letter T.
`
`9.
`
`Moreover, the goods covered in the Application are related to products and
`
`services offered by Opposer under its NOVARTIS mark, such that consumer confusion is likely
`
`to result.
`
`10.
`
`Upon information and belief, Applicant applied to register the NOVARIS mark
`
`with full knowledge of Opposer’s rights to the NOVARTIS mark and with full knowledge of
`
`Opposer’s then-existing federal trademark registrations for the NOVARTIS mark.
`
`1 1.
`
`The registration of Applicant’s mark is inconsistent with Opposer’s prior rights in
`
`the NOVARTIS mark and is inconsistent with Opposer’s statutory grant of exclusivity of use of
`
`the registered NOVARTIS mark, and would destroy Opposer’s investment and goodwill in its
`
`NOVARTIS mark.
`
`12.
`
`The mark NOVARIS sought to be registered by Applicant is so similar to
`
`Opposer’s NOVARTIS mark as to be likely to cause confusion, or to cause mistake, or to
`
`deceive the purchasing public by creating the erroneous impression that Applicant’s goods are
`
`authorized, licensed or sponsored by Opposer, or in some other way connected with Opposer.
`
`As such, any use or registration of the mark NOVARIS by Applicant would violate Section 2(d)
`
`ofthe Lanham Act, 15 U.S.C. § l052(d).
`
`13.
`
`Because Opposer’s NOVARTIS mark is famous, Applicant’s use and registration
`
`of a highly similar mark NOVARIS will dilute the distinctiveness of Opposer’s mark by blurring
`
`(FlS25865 ]
`
`)
`
`3
`
`

`
`or tarnishing it. Accordingly, Applicant’s use and registration of NOVARIS is in Violation of
`
`Section 43(c) of the Federal Trademark Act, 15 U.S.C. § 1l25(c).
`
`14.
`
`By reason of the foregoing, Opposer is likely to be harmed by registration of the
`
`Application for Applicant’s Mark.
`
`WHEREFORE, it is respectfully requested that this opposition be sustained and that the
`
`registration sought by Applicant in Application Serial No. 85/469,498 be denied.
`
`Dated: New York, New York
`September 15, 2014
`
`FROSS ZELNICK LEHRMAN & ZISSU, P.C.
`
`pg
`
`-
`
`
`
`/7 1
`
`By:
`
`3 '--;f .5
`iolin P. Margiotta
`866 United Nations Plaza
`
`New York, New York 10017
`
`(212) 813-5900
`jmargiotta@fzlz.com
`
`Attorneys for the Opposer
`
`{F152S865.l )
`
`4
`
`

`
`EXHIBIT A
`
`

`
`Generated on: This page was generated by TSDR on 2014-09-15 15:08:58 EDT
`
`Mark: NOVARTIS
`
`US Serial Number: 75131409
`
`US Registration Number: 2336960
`
`Register: Principal
`
`Mark Type: Trademark, Service Mark
`
`Status: The registration has been renewed.
`
`Application Filing Date: Jul. 09, 1996
`
`Registration Date: Apr. 04, 2000
`
`Status Date: Mar. 25, 2010
`
`Publication Date: Jul. 28, 1998
`
`
`
`Mark Literal Elements: NOVARTIS
`
`Standard Character Claim: No
`
`Mark Information
`
`Mark Drawing Type: 1 - TYPESET WORD(S) /LETTER(S) /NUMBER(S)
`Foreign Information
`
`Priority Claimed: Yes
`
`Foreign Application
`Number:
`
`01044/1996
`
`Foreign Registration
`Number:
`
`427370
`
`Foreign
`Application/Registration
`Country:
`
`SWITZERLAND
`
`Foreign Application Filing
`Date:
`
`Feb. 15, 1996
`
`Foreign Registration Date: Feb. 15, 1996
`
`Foreign Expiration Date: Feb. 15, 2006
`
`Goods and Services
`
`Note: The following symbols indicate that the registrant/owner has amended the goods/services:
`
`Brackets [..] indicate deleted goods/services;
`Double parenthesis ((..)) identify any goods/services not claimed in a Section 15 affidavit of incontestability; and
`Asterisks *..* identify additional (new) wording in the goods/services.
`
`For: [ chemicals and chemical preparations for use in industry, agriculture, horticulture and forestry, namely, chemicals for use in
`manufacturing optical lenses; Adjuvants for use in manufacturing agricultural preparations; Adjuvants for use in manufacturing
`pharmaceutical preparations; Chemical additives for use in manufacturing - pharmaceutical preparations, defoliants, wound pastes for
`trees and plants, plant growth regulators, preparations for the treatment of seeds, preparations for the protection of seeds and plants
`against plant pathogens, plant protection agents of a prophylactic nature; and Manures ]
`
`International Class(es): 001 - Primary Class
`
`U.S Class(es): 001, 005, 006, 010, 026, 046
`
`Class Status: SECTION 8 - CANCELLED
`
`Basis: 44(e)
`
`For: pharmaceutical preparations for the treatment of - dermatological, cardiovascular, hematological, bone, respiratory, central nervous
`system, endocrinological, circulatory, gastroenterological, hormonal and diabetic disorders, coughs, colds, influenza, headaches,
`stomach and digestive disorders, muscular and/or rheumatic disorders, anti-inflammatory agents, immune system disorders and
`related diseases, allergic reactions, metabolic disorders, anti-infectives, occular disorders, and for use in oncology; diagnostic
`preparations and/or reagents for clinical or medical laboratory use; Contact lens and eyecare solutions and preparations, namely,
`disinfectants, cleaning solutions, saline solutions and wetting solutions; Nicotine for medicinal purposes in liquid, pill, tablet, caplet,
`powder or transdermal patch form; [ Hormones; ] Dietetic substances for medical purposes, namely, nutritional, vitamin, [ herbal and ]
`mineral supplements and preparations, nutritional drink mix for use as a meal replacement, [ nutritional supplements in snack bar form
`for use as a meal replacement; ] Food and beverages for [ babies, ] nfants and invalids, namely, [ baby food, infant formula, ] food for
`enteral administration and food for medically restricted diets; and [ Pesticides, ] fungicides, [ herbicides ] and insecticides, all for
`commercial, [ agricultural ] and/or domestic use
`
`International Class(es): 005 - Primary Class
`
`U.S Class(es): 006, 018, 044, 046, 051, 052
`
`Class Status: ACTIVE
`
`Basis: 44(e)
`
`For: [ contact lenses; Eyeglasses; Sunglasses; and Optical lenses not for medical use ]
`
`International Class(es): 009 - Primary Class
`
`U.S Class(es): 021, 023, 026, 036, 038
`
`Class Status: SECTION 8 - CANCELLED
`
`Basis: 44(e)
`
`

`
`For: [ artificial or biological skin tissue for subsequent implantation; Intraocular lenses ]
`
`International Class(es): 010 - Primary Class
`
`U.S Class(es): 026, 039, 044
`
`Class Status: SECTION 8 - CANCELLED
`
`Basis: 44(e)
`
`For: [ prepared entrees consisting primarily of meat, fish, poultry, game and/or vegetables; Meat extracts; Preserved, dried, frozen or
`cooked fruits and vegetables; Jams and fruit or vegetable preserves; Fruit-based snack foods; Fruit toppings; Dairy products, excluding
`ice cream, ice milk and frozen yogurt; Milk ]
`
`International Class(es): 029 - Primary Class
`
`U.S Class(es): 046
`
`Class Status: SECTION 8 - CANCELLED
`
`Basis: 44(e)
`
`For: [ ready to eat snack bars made from combinations of cereal, fruit, grains and nuts; Breakfast and processed cereals; Cereal based
`snack foods; Bread; Biscuits; Chocolate; Candy; Cocoa; Sugar; Tapioca; Sago; Rusks; Desserts, namely, cakes and puddings; Malt for
`food purposes; Ice cream, frozen yogurt, ice milk and ice cream substitute; Chocolate syrup; Corn syrup; and Food additives for non-
`nutritional purposes for use as a flavoring, ingredient or filler ]
`
`International Class(es): 030 - Primary Class
`
`U.S Class(es): 046
`
`Class Status: SECTION 8 - CANCELLED
`
`Basis: 44(e)
`
`For: [ bran, cereal and protein based foodstuffs for animals; Vegetable, fruit and flower seeds for agricultural and horticultural purposes;
`Fresh fruits and vegetables; Living plants and live flowers ]
`
`International Class(es): 031 - Primary Class
`
`U.S Class(es): 001, 046
`
`Class Status: SECTION 8 - CANCELLED
`
`Basis: 44(e)
`
`For: [ non-alcoholic beverages, namely, soft drinks, fruit drinks, fruit juices; Concentrates, syrups or powders used in the preparation of soft
`drinks; and Fruit syrups used in the preparation of soft drinks ]
`
`International Class(es): 032 - Primary Class
`
`U.S Class(es): 045, 046, 048
`
`Class Status: SECTION 8 - CANCELLED
`
`Basis: 44(e)
`
`For: [ engineering services; plant, tree and seed breeding services; Horticultural services; Printing; and Material testing ]
`
`International Class(es): 042 - Primary Class
`
`U.S Class(es): 100, 101
`
`Class Status: SECTION 8 - CANCELLED
`
`Basis: 44(e)
`
`Basis Information (Case Level)
`
`Filed Use: No
`
`Filed ITU: No
`
`Filed 44D: Yes
`
`Filed 44E: No
`
`Filed 66A: No
`
`Filed No Basis: No
`
`Currently Use: No
`
`Currently ITU: No
`
`Currently 44D: No
`
`Currently 44E: Yes
`
`Currently 66A: No
`
`Amended Use: No
`
`Amended ITU: No
`
`Amended 44D: No
`
`Amended 44E: Yes
`
`Currently No Basis: No
`Current Owner(s) Information
`
`Owner Name: NOVARTIS AG
`
`Owner Address: CH-4002 BASEL
`CH-4002 BASEL
`SWITZERLAND
`
`Legal Entity Type: CORPORATION
`
`State or Country Where
`Organized:
`Attorney/Correspondence Information
`
`SWITZERLAND
`
`Attorney Name: NANCY SABARRA
`
`Correspondent
`Name/Address:
`
`NANCY SABARRA
`FROSS ZELNICK LEHRMAN ZISSU, P.C.
`866 UNITED NATIONS PLAZA
`NEW YORK, NEW YORK 10017
`UNITED STATES
`
`Attorney of Record
`Docket Number: NOCH-0511449
`
`Correspondent
`
`

`
`Domestic Representative
`Name:
`
`Domestic Representative
`FROSS ZELNICK LEHRMAN & ZISSU, P.C.
`
`Prosecution History
`
`Date
`
`Description
`
`Mar. 25, 2010
`Mar. 25, 2010
`Mar. 24, 2010
`Mar. 23, 2010
`Jun. 23, 2006
`Jun. 21, 2006
`Apr. 03, 2006
`Apr. 12, 2006
`Apr. 03, 2006
`Aug. 05, 2004
`Apr. 04, 2000
`Feb. 17, 2000
`Feb. 17, 2000
`Nov. 02, 1998
`Aug. 25, 1998
`Jul. 28, 1998
`Jun. 26, 1998
`Apr. 23, 1998
`Mar. 13, 1998
`Mar. 05, 1998
`Sep. 04, 1997
`Jul. 10, 1997
`Jan. 07, 1997
`Dec. 23, 1996
`Dec. 06, 1996
`
`REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
`REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
`CASE ASSIGNED TO POST REGISTRATION PARALEGAL
`TEAS SECTION 8 & 9 RECEIVED
`REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
`ASSIGNED TO PARALEGAL
`REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
`CASE FILE IN TICRS
`PAPER RECEIVED
`PAPER RECEIVED
`REGISTERED-PRINCIPAL REGISTER
`OPPOSITION TERMINATED NO. 999999
`OPPOSITION DISMISSED NO. 999999
`OPPOSITION INSTITUTED NO. 999999
`OPPOSITION PAPERS RECEIVED AT TTAB
`PUBLISHED FOR OPPOSITION
`NOTICE OF PUBLICATION
`APPROVED FOR PUB - PRINCIPAL REGISTER
`CORRESPONDENCE RECEIVED IN LAW OFFICE
`INQUIRY AS TO SUSPENSION MAILED
`LETTER OF SUSPENSION MAILED
`CORRESPONDENCE RECEIVED IN LAW OFFICE
`NON-FINAL ACTION MAILED
`ASSIGNED TO EXAMINER
`ASSIGNED TO EXAMINER
`Maintenance Filings or Post Registration Information
`
`Proceeding
`Number
`70131
`
`70131
`
`59807
`59807
`
`112049
`112049
`112049
`
`73365
`72506
`
`Affidavit of Continued
`Use:
`
`Section 8 - Accepted
`
`Affidavit of
`Incontestability:
`
`Section 15 - Accepted
`
`Renewal Date: Apr. 04, 2010
`
`Change in Registration: Yes
`
`TM Staff and Location Information
`
`Current Location: GENERIC WEB UPDATE
`
`TM Staff Information - None
`File Location
`
`Date in Location: Mar. 25, 2010
`Proceedings
`
`Summary
`
`Number of Proceedings: 11
`
`Proceeding Number: 91123659
`
`Status: Terminated
`
`Interlocutory Attorney: JYLL S TAYLOR
`
`Type of Proceeding: Opposition
`
`
`
`Filing Date:
`
`Status Date: Jun 29, 2005
`
`

`
`Name:
`
`INNOVATIS GMBH
`
`Correspondent Address: Julie B Seyler
`ABELMAN, FRAYNE & SCHWAB
`666 Third Avenue
`NEW YORK NY , 10017
`UNITED STATES
`
`Associated marks
`
`Mark
`
`INNOVATIS VISION AND TECHNOLOGY
`
`Name: NOVARTIS AG
`
`Correspondent Address: Nancy Sabarra
`Fross Zelnick Lehrman & Zissu
`866 United Nations Plz
`New York NY , 10017
`UNITED STATES
`
`Associated marks
`
`Defendant
`
`Application Status
`
`Cancelled - Section 8
`Plaintiff(s)
`
`Serial
`Number
`75799518
`
`Registration
`Number
`3038633
`
`Application Status
`
`Serial Number
`
`Renewed
`Prosecution History
`
`75131409
`
`Registration
`Number
`2336960
`
`Mark
`
`NOVARTIS
`
`Entry
`Number
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`
`11
`12
`13
`
`14
`15
`
`16
`
`17
`
`18
`19
`20
`
`21
`22
`23
`
`Due Date
`
`Sep 29, 2001
`
`History Text
`
`FILED AND FEE
`
`NOTICE SENT; TRIAL DATES RESET; ANSWER DUE
`
`PENDING, INSTITUTED
`
`D'S MOT FOR EXTEN. OF TIME W/ CONSENT
`
`D'S MOTION FOR AN EXTENSION OF TIME
`
`D'S MOTION FOR AN EXTENSION OF TIME
`
`SUSPENDED
`
`ANSWER
`
`STIPULATED AMENDMENT AND SUSPENSION
`
`PARTIES ARE ALLOWED UNTIL 9/4/03 TO NEGOTIATE
`SETTLEMENT; PROC REMAIN SUSPENDED
`
`D'S MOTION FOR AN EXTENSION OF TIME
`
`D'S REQ TO AMEND AND SUSPEND W/CON
`
`BOARD'S ORDER: PROCEEDING REMAIN OTHERWISE
`SUSPENDED 30 DAYS
`
`RETURNED MAIL
`
`DEF REQ TO AMEND GOODS AND SERVICES AND TO
`SUSPEND
`DEF'S REQ TO EXT TERM AND AMEND GOODS AND
`SERVICES
`Amendment approved &entered; Opposer allowed 30 days to
`respond
`
`RETURNED MAIL
`
`#17 Remailed
`
`D'S CONSENTED REQ TO AMEND GOODS AND SERVICES
`AND TO SUSPEND PROCEEDINGS
`
`Date
`
`Sep 09, 2001
`Aug 20, 2001
`Aug 20, 2001
`Mar 04, 2002
`May 03, 2002
`Jul 25, 2002
`Aug 23, 2002
`Sep 28, 2001
`Feb 13, 2003
`Aug 04, 2003
`
`Aug 29, 2003
`Oct 06, 2003
`Jun 29, 2004
`
`Jul 20, 2004
`Aug 05, 2004
`
`Aug 02, 2004
`
`Nov 15, 2004
`
`Nov 24, 2004
`Mar 25, 2005
`Apr 14, 2005
`
`WITHDRAWAL OF OPP W/O PREJ
`
`BD'S DECISION: DISMISSED W/O PREJUDICE
`
`TERMINATED
`
`Proceeding Number: 91206628
`
`Status: Terminated
`
`Interlocutory Attorney: ELIZABETH WINTER
`
`Jun 10, 2005
`Jun 29, 2005
`Jun 29, 2005
`Type of Proceeding: Opposition
`Filing Date: Aug 20, 2012
`
`Status Date: Aug 24, 2012
`
`Name: M&R of Fredericktown Limited, Inc.
`
`Defendant
`
`

`
`Correspondent Address: JOSEPH E OLIVER
`JOSEPH E OLIVER CO
`230 WHITE POND DR, SUITE A
`AKRON OH , 44313-7239
`UNITED STATES
`
`Correspondent e-mail: jeoco2@aol.com
`
`Associated marks
`
`Mark
`
`NOVARIS
`
`Application Status
`
`Abandoned - After Inter-Partes Decision
`Plaintiff(s)
`
`Serial
`Number
`85469498
`
`Registration
`Number
`
`Name: Novartis AG
`
`Correspondent Address: JOHN P MARGIOTTA
`FROSS ZELNICK LEHRMAN & ZISSU PC
`866 UNITED NATIONS PLAZA
`NEW YORK NY , 10017
`UNITED STATES
`
`Correspondent e-mail: jm@fzlz.com , agreenberg@fzlz.com
`
`Associated marks
`
`Mark
`
`NOVARTIS
`
`NOVARTIS
`
`Entry
`Number
`
`1
`2
`3
`4
`5
`6
`
`History Text
`
`FILED AND FEE
`
`PENDING, INSTITUTED
`
`WITHDRAWAL OF APPLICATION
`
`BOARD'S DECISION: SUSTAINED
`
`TERMINATED
`
`NOTICE AND TRIAL DATES SENT; ANSWER DUE:
`
`Sep 29, 2012
`
`Application Status
`
`Renewed
`Section 8 and 15 - Accepted and
`Acknowledged
`Prosecution History
`
`Serial
`Number
`75131409
`
`Registration
`Number
`2336960
`
`78365657
`
`2997235
`
`Date
`
`Due Date
`
`Aug 20, 2012
`Aug 20, 2012
`Aug 20, 2012
`Aug 22, 2012
`Aug 24, 2012
`Aug 24, 2012
`Type of Proceeding: Opposition
`Filing Date: Mar 21, 2012
`
`Status Date: Jul 02, 2012
`
`Defendant
`
`Proceeding Number: 91204423
`
`Status: Terminated
`
`Interlocutory Attorney: MICHAEL B ADLIN
`
`Name: Defiante Farmacêutica, S.A.
`
`Correspondent Address: PAOLA A STRINO
`LUCAS AND MERCANTI LLP
`15TH FLOOR, 475 PARK AVENUE SOUTH
`NEW YORK NY , 10016
`UNITED STATES
`
`Correspondent e-mail: info@lmiplaw.com
`
`Associated marks
`
`Mark
`
`ONVERTIS
`
`Application Status
`
`Abandoned - After Inter-Partes Decision
`Plaintiff(s)
`
`Serial
`Number
`79094917
`
`Registration
`Number
`
`Name: Novartis AG
`
`Correspondent Address: JOHN P MARGIOTTA
`FROSS ZELNICK LEHRMAN & ZISSU PC
`866 UNITED NATIONS PLAZA
`NEW YORK NY , 10017
`UNITED STATES
`
`Correspondent e-mail: jm@fzlz.com,jmargiotta@fzlz.com , agreenberg@fzlz.com
`
`Associated marks
`
`Mark
`
`NOVARTIS
`
`Application Status
`
`Renewed
`Section 8 and 15 - Accepted and
`
`Serial
`Number
`75131409
`
`Registration
`Number
`2336960
`
`

`
`NOVARTIS
`
`Entry
`Number
`
`1
`2
`3
`4
`5
`6
`
`History Text
`
`FILED AND FEE
`
`PENDING, INSTITUTED
`
`NOTICE OF DEFAULT
`
`BOARD'S DECISION: SUSTAINED
`
`TERMINATED
`
`NOTICE AND TRIAL DATES SENT; ANSWER DUE:
`
`May 02, 2012
`
`Acknowledged
`Prosecution History
`
`78365657
`
`2997235
`
`Date
`
`Due Date
`
`Mar 21, 2012
`Mar 23, 2012
`Mar 23, 2012
`May 17, 2012
`Jul 02, 2012
`Jul 02, 2012
`Type of Proceeding: Opposition
`Filing Date: Nov 22, 2010
`
`Status Date: Dec 15, 2011
`
`Defendant
`
`Proceeding Number: 91197509
`
`Status: Terminated
`
`Interlocutory Attorney: GEORGE POLOGEORGIS
`
`Name: Sheila Mikhail
`
`Correspondent Address: SHEILA MIKHAIL
`870 MARTIN LUTHER KING JR BLVD
`CHAPEL HILL NC , 27514-2600
`UNITED STATES
`
`Correspondent e-mail: kbatson@lifescilaw.com,smikhail@lifescilaw.com , rgiddings@lifescilaw.com
`
`Associated marks
`
`Mark
`
`NOVATI AT THE HEART OF INNOVATION
`
`Application Status
`
`Serial Number
`
`Registered
`
`77786912
`
`Registration
`Number
`4143021
`
`Plaintiff(s)
`
`Name: Novartis AG
`
`Correspondent Address: JOHN P MARGIOTTA
`FROSS ZELNICK LEHRMAN & ZISSU PC
`866 UNITED NATIONS PLAZA
`NEW YORK NY , 10017
`UNITED STATES
`
`Correspondent e-mail: jm@fzlz.com , jmargiotta@frosszelnick.com , aleipsic@frosszelnick.com
`
`Associated marks
`
`Mark
`
`NOVARTIS
`
`NOVARTIS
`
`Entry
`Number
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`13
`14
`
`Application Status
`
`Section 8 and 15 - Accepted and
`Acknowledged
`Renewed
`Prosecution History
`
`History Text
`
`FILED AND FEE
`
`NOTICE AND TRIAL DATES SENT; ANSWER DUE:
`
`PENDING, INSTITUTED
`
`STIP TO SUSPEND PEND SETTLEMENT NEGOTNS
`
`SUSPENDED
`
`STIP TO SUSPEND PEND SETTLEMENT NEGOTNS
`
`SUSPENDED
`
`STIP TO SUSPEND PEND SETTLEMENT NEGOTNS
`
`SUSPENDED
`
`STIP TO SUSPEND PEND SETTLEMENT NEGOTNS
`
`SUSPENDED
`
`MOTION TO AMEND APPLICATION
`
`RESPONSE DUE 30 DAYS (DUE DATE)
`
`WITHDRAWAL OF OPPOSITION
`
`Date
`
`Nov 22, 2010
`Nov 22, 2010
`Nov 22, 2010
`Dec 14, 2010
`Dec 14, 2010
`Mar 30, 2011
`Mar 30, 2011
`Jun 22, 2011
`Jun 24, 2011
`Sep 27, 2011
`Sep 27, 2011
`Nov 02, 2011
`Nov 16, 2011
`Dec 09, 2011
`
`Serial
`Number
`
`Registration
`Number
`
`78365657
`
`2997235
`
`75131409
`
`2336960
`
`Due Date
`
`Jan 01, 2011
`
`Dec 16, 2011
`
`

`
`BD'S DECISION: DISMISSED W/O PREJUDICE
`
`15
`16
`
`TERMINATED
`
`Proceeding Number: 91191925
`
`Status: Terminated
`
`Interlocutory Attorney: CHERYL S GOODMAN
`
`Dec 15, 2011
`Dec 15, 2011
`Type of Proceeding: Opposition
`Filing Date: Sep 16, 2009
`
`Status Date: Dec 27, 2009
`
`Defendant
`
`Name: Beautiful Ideas Group Inc.
`
`Correspondent Address: Matthew H. Swyers, Esq.
`THE TRADEMARK COMPANY, PLLC
`344 MAPLE AVE W STE 151
`VIENNA VA , 22180
`UNITED STATES
`
`Correspondent e-mail: admin@TheTrademarkCompany.com
`
`Associated marks
`
`Mark
`
`NOVORIS
`
`Application Status
`
`Abandoned - After Inter-Partes Decision
`Plaintiff(s)
`
`Serial
`Number
`77522060
`
`Registration
`Number
`
`Name: Novartis AG
`
`Correspondent Address: John P. Margiotta
`Fross Zelnick Lehrman & Zissu, P.C.
`866 United Nations Plaza
`New York NY , 10017
`UNITED STATES
`
`Correspondent e-mail: jm@fzlz.com
`
`Associated marks
`
`Mark
`
`NOVARTIS
`
`NOVARTIS
`
`Entry
`Number
`
`1
`2
`3
`4
`5
`6
`
`History Text
`
`FILED AND FEE
`
`PENDING, INSTITUTED
`
`NOTICE OF DEFAULT
`
`BOARD'S DECISION: SUSTAINED
`
`TERMINATED
`
`NOTICE AND TRIAL DATES SENT; ANSWER DUE:
`
`Serial
`Number
`
`Registration
`Number
`
`78365657
`
`2997235
`
`75131409
`
`2336960
`
`Due Date
`
`Oct 26, 2009
`
`Application Status
`
`Section 8 and 15 - Accepted and
`Acknowledged
`Renewed
`Prosecution History
`
`Date
`
`Sep 16, 2009
`Sep 16, 2009
`Sep 16, 2009
`Nov 12, 2009
`Dec 27, 2009
`Dec 27, 2009
`Type of Proceeding: Opposition
`Filing Date: Sep 14, 2009
`
`Proceeding Number: 91191898
`
`Status: Terminated
`
`Interlocutory Attorney: GEORGE POLOGEORGIS
`
`Name: Mitsubishi Chemical Corporation
`
`Correspondent Address: PERLA M. KUHN
`HUGHES HUBBARD & REED LLP
`1 BATTERY PARK PLZ
`NEW YORK NY , 10004
`UNITED STATES
`
`Correspondent e-mail: kuhn@hugheshubbard.com
`
`Associated marks
`
`Mark
`
`NOVATI
`
`Name: Novartis AG
`
`Correspondent Address: John P. Margiotta
`
`Status Date: Dec 11, 2009
`
`Defendant
`
`Application Status
`
`Abandoned - No Statement Of Use Filed
`Plaintiff(s)
`
`Serial
`Number
`77557248
`
`Registration
`Number
`
`

`
`Fross Zelnick Lehrman & Zissu, P.C.
`866 United Nations Plaza6th floor
`New York NY , 10017
`UNITED STATES
`
`Correspondent e-mail: JMargiotta@frosszelnick.com
`
`Associated marks
`
`Application Status
`
`Section 8 and 15 - Accepted and
`Acknowledged
`Renewed
`Prosecution History
`
`Date
`
`History Text
`
`FILED AND FEE
`
`Mark
`
`NOVARTIS
`
`NOVARTIS
`
`Entry
`Number
`
`1
`2
`3
`4
`5
`6
`7
`8
`9
`10
`11
`12
`
`Serial
`Number
`
`Registration
`Number
`
`78365657
`
`2997235
`
`75131409
`
`2336960
`
`Due Date
`
`Oct 24, 2009
`
`Jan 09, 2010
`
`NOTICE AND TRIAL DATES SENT; ANSWER DUE:
`
`PENDING, INSTITUTED
`
`STIP TO SUSPEND PEND SETTLEMENT NEGOTNS
`
`SUSPENDED
`
`MOTION TO AMEND APPLICATION
`
`STIPULATION FOR AN EXTENSION OF TIME
`
`EXTENSION OF TIME GRANTED
`
`RESPONSE DUE 30 DAYS (DUE DATE)
`
`WITHDRAWAL OF OPPOSITION
`
`BOARD'S DECISION: DISMISSED
`
`TERMINATED
`
`Proceeding Number: 91185601
`
`Status: Terminated
`
`Interlocutory Attorney: FRANCES S WOLFSON
`
`Sep 14, 2009
`Sep 14, 2009
`Sep 14, 2009
`Sep 24, 2009
`Sep 24, 2009
`Nov 20, 2009
`Dec 10, 2009
`Dec 10, 2009
`Dec 10, 2009
`Dec 11, 2009
`Dec 11, 2009
`Dec 11, 2009
`Type of Proceeding: Opposition
`Filing Date: Aug 05, 2008
`
`Status Date: Nov 17, 2008
`
`Defendant
`
`Name: Mario V. Sorci and Novaeris L.L.C.
`
`Correspondent Address: NOVAERIS L.L.C.
`NOVAERIS L.L.C.
`24301 ROBERTS DRIVE, STE A
`BLACK DIAMOND WA , 98010-9219
`UNITED STATES
`
`Correspondent e-mail: mario@aesol.com
`
`Associated marks
`
`Mark
`
`NOVAERIS
`
`Application Status
`
`Abandoned - After Inter-Partes Decision
`Plaintiff(s)
`
`Serial
`Number
`77309403
`
`Registration
`Number
`
`Name: Novartis AG
`
`Correspondent Address: John P. Margiotta
`Fross Zelnick Lehrman & Zissu, P.C.
`866 United Nations Plaza
`New York NY , 10017
`UNITED STATES
`
`Correspondent e-mail: jmargiotta@frosszelnick.com
`
`Associated marks
`
`Mark
`
`NOVARTIS
`
`NOVARTIS
`
`Entry
`Number
`
`Application Status
`
`Section 8 and 15 - Accepted and
`Acknowledged
`Renewed
`Prosecution History
`
`Serial
`Number
`
`Registration
`Number
`
`78365657
`
`2997235
`
`75131409
`
`2336960
`
`History Text
`
`Date
`
`Due Date
`
`

`
`1
`2
`3
`4
`5
`6
`
`FILED AND FEE
`
`NOTICE AND TRIAL DATES SENT; ANSWER DUE:
`
`Sep 14, 2008
`
`Aug 05, 2008
`Aug 05, 2008
`Aug 05, 2008
`Sep 29, 2008
`Nov 17, 2008
`Nov 17, 2008
`Type of Proceeding: Opposition
`Filing Date: Nov 05, 2007
`
`Status Date: Mar 14, 2008
`
`Defendant
`
`PENDING, INSTITUTED
`
`NOTICE OF DEFAULT
`
`BOARD'S DECISION: SUSTAINED
`
`TERMINATED
`
`Proceeding Number: 91180607
`
`Status: Terminated
`
`Interlocutory Attorney: ANDREW P BAXLEY
`
`Name: TAVARTIS GmbH
`
`Correspondent Address: Joyce H. A. von Natzmer
`Pequignot + Myers LLC
`200 Madison Ave., Suite 1901
`New York NY , 10016
`UNITED STATES
`
`Correspondent e-mail: natzmer@natzmer-law.